Case report: use of Lenzilumab and Tocilizumab for the Treatment of Coronavirus Disease 2019
Megan Melody, Jared Nelson, Jacquelyn Hastings, Joshua Propst, Michael Smerina, Julio Mendez, Pramod Guru
Abstract
This case demonstrates the effective use of tocilizumab in the treatment of COVID-19 and suggests the superiority of tocilizumab over lenzilumab in the management of this cytokine-mediated syndrome.
Topics & Concepts
TocilizumabMedicineCytokine release syndromeHydroxychloroquineMacrophage activation syndromeCytokineImmunologyCoronavirus disease 2019 (COVID-19)Interleukin 6CoronavirusInternal medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research